Cargando…
Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
Autores principales: | Conde, João, Tian, Furong, de la Fuente, Jesus M., Baptista, Pedro V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701939/ https://www.ncbi.nlm.nih.gov/pubmed/26779477 http://dx.doi.org/10.3389/fchem.2015.00071 |
Ejemplares similares
-
Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
por: Abdulmawjood, Bilal, et al.
Publicado: (2021) -
Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020) -
COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020) -
The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013) -
Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)